Exchange: NASDAQ·Updated 01:49 PM EDT
PMCB logo

PMCB PharmaCyte Biotech Inc

$0.4889
$0.0024
(0.49%)
Today
Reported EarningsMay 27
Mkt Cap$5.27M
Vol13,117.00

About PMCB

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.
38

Bearish Sentiment

How do you feel about PMCB?

Advertisement|Remove ads.